Elevance Health (ELV) EPS (Basic) (2009 - 2026)

Elevance Health (ELV) has reported EPS (Basic) for 18 consecutive years, with $6.7 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 13.48% year-over-year to $6.7 in Q2 2026; TTM through Jun 2026 was $22.8, a 4.02% decrease from a year earlier, with the FY2025 full-year figure at $25.27, down 1.93% from the prior year.
• EPS (Basic) was $6.7 for Q2 2026 at Elevance Health, down from $8.01 in the prior quarter.
• Over five years, EPS (Basic) peaked at $9.91 in Q2 2024 and troughed at $1.78 in Q4 2024.
• A 5-year average of $6.41 and a median of $6.74 in 2022 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) plunged 49.4% in 2024 and jumped 36.75% in 2025, its largest moves.
• Over 5 years, EPS (Basic) stood at $3.65 in 2022, then dropped by 3.6% to $3.52 in 2023, then sank by 49.4% to $1.78 in 2024, then surged by 36.75% to $2.44 in 2025, then surged by 174.89% to $6.7 in 2026.
• The last three EPS (Basic) figures came in at $6.7 (Q2 2026), $8.01 (Q1 2026), and $2.44 (Q4 2025), per Business Quant data.